CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-09 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +450 | $3.29 | $1K | 191,037,144 |
| 2020-11-09 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +3,950 | $3.30 | $13K | 191,041,094 |
| 2020-11-09 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +20,600 | $3.30 | $68K | 191,061,694 |
| 2020-11-09 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +10,000 | $3.32 | $33K | 191,071,694 |
| 2020-10-30 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +600,000 | $3.45 | $2.1M | 190,821,694 |
| 2020-08-26 | Rubin Steven D Executive VP-Administration | Purchase | +5,000 | $3.99 | $20K | 6,162,732 |
| 2020-08-26 | Rubin Steven D Executive VP-Administration | Purchase | +2,500 | $3.99 | $10K | 6,165,232 |
| 2020-08-26 | Rubin Steven D Executive VP-Administration | Purchase | +2,500 | $4.01 | $10K | 6,167,732 |
| 2020-07-24 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-25 | Yu Alice Lin-Tsing Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-25 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-25 | PAGANELLI JOHN A Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-25 | LERNER RICHARD A Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-25 | KRASNO RICHARD M Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-25 | Fishel Robert Scott Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-04 | FROST PHILLIP MD ET AL CEO & Chairman | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2020-06-04 | HSIAO JANE PH D Vice Chairman & CTO | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2020-06-04 | Rubin Steven D Executive VP-Administration | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2020-06-04 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2020-06-03 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +100,000 | $2.27 | $227K | 190,221,694 |
Page 35 of 51 · 1,008 trades